Biomerica reports real-world data showing IBS therapy effectiveness
Go back to Biomerica reports real-world data showing IBS therapy effectiveness| Biomerica, Inc. (NASDAQ: BMRA) | Delayed: 2.37 +0.07 (3.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.30 | 52 Week High | $3.25 | |||
| Open | $2.27 | 52 Week Low | $0.80 | |||
| Day High | $2.42 | P/E | N/A | |||
| Day Low | $2.27 | EPS | $-0.06 | |||
| Volume | 13,680 | |||||
| Henry Schein, Inc. (NASDAQ: HSIC) | Delayed: 86.77 -0.75 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.52 | 52 Week High | $183.00 | |||
| Open | $87.52 | 52 Week Low | $142.64 | |||
| Day High | $88.32 | P/E | 17.60 | |||
| Day Low | $86.44 | EPS | $4.93 | |||
| Volume | 1,018,109 | |||||
